Home
Browse
Search
Statistics
About
Usage
PMID: 23546589
Takada T
[Transporter-mediated regulation of pharmacokinetics of lifestyle-related substances].
Yakugaku Zasshi. 2013;133(4):451-61.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
24
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 23546589:24:3788
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 23546589:24:4178
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 23546589:24:6626
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 23546589:24:7157
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 23546589:24:7460
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 23546589:24:7982
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 23546589:24:3635
status:
NEW
view ABCG2 p.Val12Met details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 23546589:24:3928
status:
NEW
view ABCG2 p.Gln126* details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 23546589:24:6682
status:
NEW
view ABCG2 p.Gln126* details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 23546589:24:7446
status:
NEW
view ABCG2 p.Gln126* details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 23546589:24:7968
status:
NEW
view ABCG2 p.Gln126* details
c3f; ⏚ 3fa; c8; e9; f3; b9; dd; fc; bf; fc; ABCG2 IJe; SNPs ad8;c3f;⏚⊈Kc7;fb;Kdb;ba8;ea;b9;af; ˯f;d3b;fd2;᠓Kc5; ௱௺Me5;Ĵc;Ĵb; ad8;c3f;⏚⊈Kc7;ఌKdb;ba8;IJf;,d05;ca2;Kc5;௦a00; ℁İc;Ĵb;ఐ௦IJb;,Pa5;e80;ఌ ad8;d7;ea;f3;bdf;IJe;ᤪbdf;Έe;ɏa;IJa; IJe;Jb0;⌕8e0;IJb;d77;8e0;௳Ĵb;ὃ௨Ĵc;௺ıf;İc;,fd1;e74;IJe; Ẇa76;IJb;ఐĴa;a;f1d;ḄIJa;⌕8e0;IJe;b58;ᙠఊ̙a;ᖂ௯Ĵc;௺ıf;&#ff0e; 2004 e74;,5f0;e7e;IJe;Ẇa76;b0;eb;fc;d7;ఐĴa;,d2;c8;b2c; 4 Cd3; ⁐f53;╩ΊIJb;ʠa;Me5;IJe;Kdb;ba8;Kc5;8e0;a;f1d;b50;İc;b58;ᙠ௳Ĵb;5ef;Pfd;ឋ İc;ᛇȠa;௯Ĵc;ıf;İc;, 26) Xdc;♚9df;IJb;IJf;ɏa;İf;IJe;a;f1d;b50;İc;Ȟb; ije;Ĵc;௺İa;Ĵa;,ᐹf53;ḄIJa;Kc5;8e0;a;f1d;b50;IJf;Ȝc;b9a;௯Ĵc;௺IJa; İb;௷ıf;&#ff0e;ıd;௭,d30;Pde;̳c;e0a;IJb;İa;௺f38;〈9fa;cea;IJe;3fa; IJb;fc2;Ĵf;Ĵb; ABCG2/breast cancer resistance protein (BCRP) a;f1d;b50;İc;௭IJe;♚9df;IJb;b58;ᙠ௳Ĵb;௭, ABCG2 IJb;IJf;a5f;Pfd;᜕4d5;ఔf34;௦ϗb;ea6;IJe; ad8;a;f1d;b50;ɏa;ɂb;İc;b58;ᙠ௳ Ĵb;௭,Ae2;Me5;IJe;f38;〈9fa;cea;IJe;bd4;f03;İb;c3f;⏚IJf; ABCG2 IJe;9fa;cea;IJb;IJa;Ĵa;f97;Ĵb;ὃ௨Ĵc;ıf;௭IJa;IJe;ᳮᵫIJb;ఐ Ĵa;,b46;ὅIJf; ABCG2 IJb;_a2;௳Ĵb;ʳc;a0e;ఔ⍈ఉıf;(௵IJa; ijf;IJb;,ıd;IJe;f8c;IJe; GWAS IJb;İa;௺ఊ⊈e05;c3f;⏚ᎠIJe;᜕ 4d5;IJb;_a2;⌿௳Ĵb;a;f1d;b50;௱௺ ABCG2 IJf;ᛇȠa;௯Ĵc;௺ Ĵb;) &#ff0e; 27&#e30f; 29) ABCG2/BCRP IJf;ıd;IJe;Ȝd;IJe;΅a;Ĵa;,ɏa;ᒐὊឋIJb;_a2;e0e; ௳Ĵb;8e0;b50;௱௺˿a;b;௯Ĵc;ıf;c8;e9;f3;b9;dd;fc;bf;fc;Ĵb; İc;,e83;bc4;IJa;d44;e54;ᑖe03;e83;9fa;cea;a8d;b58;ឋఔᨵ௳Ĵb;௭ İc;b21;b2c;IJb;ʔe;İb;IJa;Ĵa;,Ife;ᙠIJf;ɏa;Ed8;IJa;⌤Fb9;İb;Ẇ a76;İc;⍈ఉĴc;௺Ĵb;&#ff0e;Ae5;ʠc;eba;IJb;İa;௫Ĵb; ABCG2 a;f1d; b50;ɏa;ɂb;IJe;a2;ec;eb;ϗb;ea6;IJf; ad8;İf;,˿a;Ife;[cf;5ca;ఁa5f;Pfd;᜕ᓄఔ f34;Ĵf;IJa; 34G&#ff1e;A(
V12M
)IJf; 19.2%,bf;f3;d1;af;cea; ˿a;Ife;[cf;İc;d04;Ȗa;ᑖIJb;f4e;e0b;௳Ĵb; 421C&#ff1e;A(
Q141K
)IJf; 31.9%,d42;b62;b3;c9;f3;İc;˯f;௲a5f;Pfd;b20;ʀd;IJa;Ĵb; 376C&#ff1e;T (
Q126X
)IJf; 2.8%Ĵb;ᛇȠa;௯Ĵc;௺Ĵb;&#ff0e; 30) ௭Ĵc; IJe;௦௵,ϗb;ea6;İc; ad8;İf;a5f;Pfd;f4e;e0b;ఔf34;௦ 421C&#ff1e;A (
Q141K
)IJb;௸௺IJf;Qe8;e8a;ḄIJb;ఊఐİf;Ẇa76;௯Ĵc;௺İa; Ĵa;,Uac;ᱥ4d5;ɦb;IJe;᜕4d5;௱௺IJf;,b9;eb;d5;a1;b5;e9;b8;f3;IJe; d88;ᓄba1;ᔾ5ce;IJe;e0a;,ed;b9;d0;b9;bf;c1;f3;ఌd5;eb;d0;b9;bf;c1; f3;IJe;d4c;5e3;ᢗe0e;᧲IJe; AUC(Uac;ᱥ⊈e2d;fc3;ea6;ߟ᧲╹Bf2;dda; e0b;☢a4d;)ఌ Cmax(ᨬ ad8;⊈e2d;fc3;ea6;)IJe;e0a;İc;Yb3;bdf;௯ Ĵc;௺Ĵb;&#ff0e;௭IJe;ఐ௦IJb;,Uac;ᱥc8;e9;f3;b9;dd;fc;bf;fc; ABCG2 IJe;Uac;ᱥ4d5;ɦb;ᑴfa1;8e0;b50;௱௺IJe;[cd;⌕ឋIJf;a8d;b58; ௯Ĵc;௺ıf;ఊIJe;IJe;,d2;c8;IJb;İa;௫Ĵb;˯f;ᳮḄ9fa;cea;ఌ˯f;ᳮ a5f;Pfd;IJb;௸௺IJf;e0d;ʔe;௷ıf;&#ff0e; ABCG2 IJb;ఐĴb;c3f;⏚f38;〈IJb;௸௺ʳc;a0e;௳Ĵb;ıf;ఉ, ABCG2 ˿a;Ife;d30;Pde;İb;abf;Xfd;௱ıf;d30;Pde;̳c;c0f;Pde;ఔᵨıf; f38;〈b9f; a13;ఔʹc;௷ıf;d50;ʧc;,ABCG2 IJf;˯f;ᳮḄfc3;ea6;IJf; bfd;Ȥc;௱IJa; ad8;bb9;[cf;ឋfb;f4e;Yaa;Ȥc;ឋIJe;c3f;⏚f38;〈ఔ>c5;௦௭ İc;ʔe;İb;IJa;௷ıf;(c3f;⏚IJe;eb6;Ye3;ea6;IJe;bd4;f03;Ḅ ad8; ad8; pH e0b;c42;ఉĴc;ıf; Km ᎠIJf; 8.24&#b1;1.44 mM Ĵa;,⊈e05;c3f;⏚Ꭰ(f8b;௨ 7.0 mg/dL&#ff1d;d04; 420 mM) bd4;ఇ௺IJf;Ĵb;İb;IJb; ad8;) &#ff0e; 31) ije;ıf;,᜕ᶒf53;Ye3;᪆IJe;d50; ʧc;,ed6;IJe;f38;〈9fa;cea;Ȝc;Ed8;,c3f;⏚f38;〈IJb;İa;௺ఊ
Q141K
IJf;a5f;Pfd;İc;Ȗa;e1b;,
Q126X
IJf;a5f;Pfd;İc;d88;ᜫ௳ Ĵb;௭İc;̙a;௯Ĵc;ıf;&#ff0e; ௸௹௺,Ae5;ʠc;eba;IJe;Ꮙeb7;a3a;Aad;5d7;a3a;ὅIJe;b5;f3;d7;eb;ఔ ᵨ௺,⊈e05;c3f;⏚Ꭰ ABCG2 a;f1d;b50;ɏa;ɂb;IJe;_a2;fc2;IJb; ௸௺ʳc;a0e;௱ıf;d50;ʧc;,
Q141K
᜕ᶒIJe;fdd;ᢝᦪİc;ɏa; ijb;,⊈e05;c3f;⏚Ꭰİc;e0a;௱௺ıf;&#ff0e; 31) ije;ıf;,cf;d7;ed; bf;a4;d7;ϗb;ea6;Ye3;᪆IJb;ఐĴa;,
Q126X
Q141K
IJe;e21;᜕ᶒ 4. Proposed Model of ABCG2-mediated Urate Secretion31) 458 Vol. 133 (2013) IJf;Ȝc;௲Cd3;⁐f53;e0a;IJb;IJf;b58;ᙠ௱IJa;௭İc;̙a;௯Ĵc;ıf;&#ff0e;ıd; ௭,e21;᜕ᶒIJe;ϗb;ea6;IJb;௸௺Ae5;ʠc;eba;ᵱឋIJe;Kdb;ba8;Kc7;f8b; Ꮙe38;ὅbd4;f03;௱ıf;d50;ʧc;,
Q126X
Q141K
IJe;d44;ijf; ᔠĴf;ıb;İb;?a8;b9a;௯Ĵc;Ĵb;c3f;⏚f38;〈d3b;ឋIJe;f4e;e0b;IJb;f34;, aa;c3;ba;bd4;̙a;௯Ĵc;Ĵb;Kdb;ba8;˿a;Kc7;ea;b9;af;İc;♿℉IJb; ad8;ije;Ĵb; ௭ İc; ʔe; İb; IJa; ௷ ıf; &#ff0e; 31) ௭ Ĵc; IJe; d50; ʧc; IJf; , ABCG2 İc;˯f;f53;ᑁIJb;İa;௫Ĵb;c3f;⏚IJe;f53;ఆIJe;cc4;IJb;_a2; e0e;௱௺İa;Ĵa;,ıd;IJe;a5f;Pfd;f4e;e0b;IJf;⊈e05;c3f;⏚Ꭰ31,32)5ca;ఁKdb; ba8;˿a;Kc7;ea;b9;af;31)IJe;e0a;ఔఊıf;௳௭ఔ̙a;௳ఊIJe; ௷ıf;&#ff0e;ABCG2 IJf;̩d;Qd3;,̮e;Qd3;,c0f;ῲIJa;IJe;♊aef;̳c; IJb;˿a;Ife;௱,f38;〈9fa;cea;IJe;f53;ఆIJe;3fa;IJb;fc2;Ĵf;Ĵb;௭İc; Me5;Ĵc;௺Ĵb;௭,c3f;⏚IJf;c3f;e2d;IJe;ijf;IJa;ıa;cde;e2d;IJb;ఊ cc4; ௯ Ĵc; Ĵb; ௭ İc; ᛇ Ƞa; ௯ Ĵc; ௺ ıf; ௭ İb; , ABCG2 IJf;௭Ĵc;IJe;d44;e54;İb;IJe;c3f;⏚ᑖccc;IJb;_a2;e0e;௱௺ Ĵb;5ef;Pfd;ឋİc;ὃ௨Ĵc;ıf;(Fig. 4) &#ff0e; 31) 5-2.
Login to comment